⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31555003 | 0.75 | — | — | |
| SCHEMBL31358620 | 0.75 | — | — | |
| SCHEMBL18398540 | 0.75 | — | — | |
| SCHEMBL23181530 | 0.75 | — | — | |
| SCHEMBL897963 | 0.75 | — | — | |
| SCHEMBL23440994 | 0.75 | — | — | |
| SCHEMBL4474333 | 0.75 | — | — | |
| SCHEMBL677215 | 0.75 | — | — | |
| SCHEMBL21598599 | 0.75 | — | — | |
| SCHEMBL31194201 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4663634-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | Kyulux, Inc. (JP) | 2025-12-17 | — | — | EP | disclosed |
| WO-2025224168-A1 | ARYL SULFONE AND SULFANONE DERIVATIVES AS OREXIN RECEPTOR MODULATORS | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-10-30 | — | — | WO | disclosed |
| WO-2025069870-A1 | COMPOUND, LUMINESCENT MATERIAL, AND LUMINESCENT ELEMENT | 株式会社Kyulux | 2025-04-03 | — | — | WO | disclosed |
| WO-2024166785-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | 株式会社Kyulux | 2024-08-15 | — | — | WO | disclosed |
| US-8883782-B2 | Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use | AMGEN INC. (US) | 2014-11-11 | — | — | US | disclosed |
| WO-2014152431-A1 | STABILIZATION OF RADIOIODINATED AND ASTATINATED PHARMACEUTIALS AND IMAGING AGENTS | Ground Fluor Pharmaceuticals, Inc. (US) | 2014-09-25 | — | — | WO | disclosed |
| US-20140275539-A1 | STABILIZATION OF RADIOIODINATED AND ASTATINATED PHARMACEUTICALS AND IMAGING AGENTS | Ground Fluor Pharmaceuticals, Inc. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140275539-A1 | STABILIZATION OF RADIOIODINATED AND ASTATINATED PHARMACEUTICALS AND IMAGING AGENTS | Ground Fluor Pharmaceuticals, Inc. (US) | 2014-09-18 | — | — | US | disclosed |
| EP-2547685-A1 | SPIRO-TETRACYCLIC RING COMPOUNDS AS BETA - SECRETASE MODULATORS | Amgen Inc. (US) | 2013-01-23 | — | — | EP | disclosed |
| US-20110251190-A1 | SPIRO-TETRACYCLIC RING COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE | AMGEN INC. (US) | 2011-10-13 | — | — | US | disclosed |
| WO-2011115938-A1 | SPIRO-TETRACYCLIC RING COMPOUNDS AS BETA - SECRETASE MODULATORS | AMGEN INC. (US) | 2011-09-22 | — | — | WO | disclosed |